Molecular Cancer (Jul 2010)

ΔNp63 transcriptionally regulates ATM to control p53 Serine-15 phosphorylation

  • Smith Graeme,
  • DiRenzo James,
  • Gueven Nuri,
  • Hrstka Roman,
  • Nekulova Marta,
  • Finlan Lee E,
  • Holcakova Jitka,
  • Craig Ashley L,
  • Hupp Ted R,
  • Vojtesek Borivoj

DOI
https://doi.org/10.1186/1476-4598-9-195
Journal volume & issue
Vol. 9, no. 1
p. 195

Abstract

Read online

Abstract Background ΔNp63α is an epithelial progenitor cell marker that maintains epidermal stem cell self-renewal capacity. Previous studies revealed that UV-damage induced p53 phosphorylation is confined to ΔNp63α-positive cells in the basal layer of human epithelium. Results We now report that phosphorylation of the p53 tumour suppressor is positively regulated by ΔNp63α in immortalised human keratinocytes. ΔNp63α depletion by RNAi reduces steady-state ATM mRNA and protein levels, and attenuates p53 Serine-15 phosphorylation. Conversely, ectopic expression of ΔNp63α in p63-null tumour cells stimulates ATM transcription and p53 Serine-15 phosphorylation. We show that ATM is a direct ΔNp63α transcriptional target and that the ΔNp63α response element localizes to the ATM promoter CCAAT sequence. Structure-function analysis revealed that the ΔNp63-specific TA2 transactivation domain mediates ATM transcription in coordination with the DNA binding and SAM domains. Conclusions Germline p63 point mutations are associated with a range of ectodermal developmental disorders, and targeted p63 deletion in the skin causes premature ageing. The ΔNp63α-ATM-p53 damage-response pathway may therefore function in epithelial development, carcinogenesis and the ageing processes.